SP

Active Director Additional Director DIN 10908238
DIN 10908238 First appointment Jan 2025 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2025
Shareholding value •••• Premium profile

About Shri Pal

Data last updated:

Shri Pal is an Additional Director at Kirvsy Pharmaceuticals Private Limited (since 2025). The company operates in Pharma. Kirvsy Pharmaceuticals Private Limited reported revenue of ₹2.42 Cr (FY 2023).

DIN 10908238
Primary Designation Additional Director
Industry Pharma
First Appointment 17 Jan 2025
Oldest Company Age 9 yrs
Largest company Kirvsy Pharmaceuticals Private Limited · ₹2.42 Cr (FY 2023)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Additional Director17 Jan 20252017₹2.42 Cr (FY 2023)Active

Board colleagues of Shri Pal

Directorship timeline

Open interactive timeline →
Kirvsy Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Shri Pal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shri Pal

Shri Pal currently holds 1 directorship: Kirvsy Pharmaceuticals Private Limited (Additional Director, since 17 Jan 2025, revenue ₹2.42 Cr (FY 2023)).

Shri Pal was first appointed on 17 Jan 2025 as Additional Director at Kirvsy Pharmaceuticals Private Limited.

The current boards of Shri Pal's companies include Mukesh Tyagi (Kirvsy Pharmaceuticals Private Limited), Rashmi Tyagi (Kirvsy Pharmaceuticals Private Limited), Vikas Kumar (Kirvsy Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available